We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 316

Standard of Review of Palpable and Overriding Error Not Applied in Appeal from Rule 51 Appeal
  • Borden Ladner Gervais LLP
  • Canada
  • January 27 2016

This is an appeal from the Federal Court's (FC) decision (2015 FC 797), which upheld the Prothonotary's decision allowing the generic Respondent's


Application to vary the ownership of patent granted where assignor inadvertently assigned rights to Gray Automotive Products, Inc., as opposed to Gray Automotive Products Co.
  • Borden Ladner Gervais LLP
  • Canada
  • February 4 2016

The Federal Court granted an application under section 52 of the Patent Act to vary all entries of the Patent Office relating to the ownership of


Court grants prohibition order; finds allegations of obviousness, lack of utility and insufficiency not justified
  • Borden Ladner Gervais LLP
  • Canada
  • January 20 2016

In a decision issued on November 18, 2015, the Federal Court allowed the proceeding, granting Leo Pharma a prohibition order in relation to its


Appeal relating to patent and industrial design dismissed
  • Borden Ladner Gervais LLP
  • Canada
  • January 20 2016

The Supreme Court dismissed 1284897 Alberta Ltd.'s appeal from the judgment of the Federal Court of Appeal (2015 FCA 115


Supreme Court to Issue Decision in Leave Application Re Claim for Unjust Enrichment in S. 8 Proceeding
  • Borden Ladner Gervais LLP
  • Canada
  • January 13 2016

The Supreme Court of Canada has announced that on Thursday, January 14, 2016 it will issue its decision in Apotex' application for leave to appeal


Court of Appeal states obviousness test is "more or less self-evident" and not "a fair expectation of success"
  • Borden Ladner Gervais LLP
  • Canada
  • January 6 2016

The Court of Appeal has dismissed the appeal of a dismissal of an application pursuant to thePM(NOC) Regulations that had found Mylan's allegations


Import Ban Quashed, and Health Canada Ordered to Retract Its Statements re Same
  • Borden Ladner Gervais LLP
  • Canada
  • January 13 2016

Apotex et al brought a judicial review of the Minister of Health's (the Minister) decision to impose an import ban on products from two of Apotex'


Astrazeneca Canada Inc. v. Apotex Inc., 2015 FC 671
  • Borden Ladner Gervais LLP
  • Canada
  • July 7 2015

The parties moved under Rule 397 to modify the terms of the judgment in the proceeding, previously reported as 2015 FC 322 and summarized in our


Documents included in joint book for trial should be exhibits for appeal
  • Borden Ladner Gervais LLP
  • Canada
  • June 11 2012

The issue to be determined relates to the contents of the appeal books


Court grants motion to reopen trial and admit new evidence
  • Borden Ladner Gervais LLP
  • Canada
  • April 27 2011

The Federal Court granted leave to reopen the trial and admit new evidence in a matter under reserve, in which no reasons or judgement have issued